- Home
- MTLS vs XOMA Comparison
MTLS vs XOMA Comparison
Compare MTLS & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- XOMA
- Stock Information
- Founded
- MTLS 1990
- XOMA 1981
- Country
- MTLS Belgium
- XOMA United States
- Employees
- MTLS N/A
- XOMA N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- XOMA Health Care
- Exchange
- MTLS Nasdaq
- XOMA Nasdaq
- Market Cap
- MTLS 349.7M
- XOMA 330.2M
- IPO Year
- MTLS 2014
- XOMA N/A
- Fundamental
- Price
- MTLS $5.13
- XOMA $32.47
- Analyst Decision
- MTLS
- XOMA Strong Buy
- Analyst Count
- MTLS 0
- XOMA 2
- Target Price
- MTLS N/A
- XOMA $69.50
- AVG Volume (30 Days)
- MTLS 127.2K
- XOMA 57.0K
- Earning Date
- MTLS 10-23-2025
- XOMA 08-13-2025
- Dividend Yield
- MTLS N/A
- XOMA N/A
- EPS Growth
- MTLS N/A
- XOMA N/A
- EPS
- MTLS 0.11
- XOMA N/A
- Revenue
- MTLS $311,850,851.00
- XOMA $44,952,000.00
- Revenue This Year
- MTLS $2.98
- XOMA $82.30
- Revenue Next Year
- MTLS $7.09
- XOMA $12.59
- P/E Ratio
- MTLS $48.31
- XOMA N/A
- Revenue Growth
- MTLS 2.98
- XOMA 194.98
- 52 Week Low
- MTLS $3.93
- XOMA $18.35
- 52 Week High
- MTLS $9.69
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- MTLS 47.90
- XOMA 61.79
- Support Level
- MTLS $5.01
- XOMA $32.60
- Resistance Level
- MTLS $5.32
- XOMA $34.60
- Average True Range (ATR)
- MTLS 0.18
- XOMA 1.82
- MACD
- MTLS 0.02
- XOMA 0.09
- Stochastic Oscillator
- MTLS 52.08
- XOMA 66.75
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.